Milestone Historical Balance Sheet

MIST Stock

USD 1.99 0.12 6.42%

Trend analysis of Milestone Pharmaceuticals balance sheet accounts such as Total Stockholder Equity of 15.9 M provides information on Milestone Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Milestone Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Milestone Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Milestone Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Milestone Pharmaceuticals is a good buy for the upcoming year.

Milestone Pharmaceuticals Inventory

(312,795)

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.

About Milestone Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Milestone Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Milestone Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Milestone Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Milestone currently owns. An asset can also be divided into two categories, current and non-current.

Milestone Pharmaceuticals Balance Sheet Chart

At this time, Milestone Pharmaceuticals' Other Stockholder Equity is comparatively stable compared to the past year. Total Current Assets is likely to gain to about 102.2 M in 2024, whereas Net Tangible Assets are likely to drop slightly above 63.9 M in 2024.

Other Current Liab Total Current Liabilities Property Plant And Equipment Net Good Will

Add Fundamental

Total Current Liabilities

Total Current Liabilities is an item on Milestone Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Milestone Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Good Will

An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.

Most accounts from Milestone Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Milestone Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.At this time, Milestone Pharmaceuticals' Other Stockholder Equity is comparatively stable compared to the past year. Total Current Assets is likely to gain to about 102.2 M in 2024, whereas Net Tangible Assets are likely to drop slightly above 63.9 M in 2024.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	1.9M	2.9M	2.2M	2.3M
Total Assets	119.8M	74.5M	75.2M	103.5M

Other Current Liab Total Assets

Milestone Pharmaceuticals balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Net Working Capital
Total Assets		0.67	0.9	0.86	0.88	0.58	-0.56	-0.63	0.96	0.77	0.58	-0.6	1.0	0.33	0.81	0.37	0.57	-0.53	0.58	0.83	0.48	-0.48	0.89	0.59	1.0	1.0
Other Current Liab	0.67		0.88	0.59	0.65	0.69	-0.33	-0.66	0.71	0.54	0.69	-0.69	0.65	0.42	0.73	0.34	0.57	-0.43	0.57	0.65	0.57	-0.38	0.65	0.7	0.66	0.64
Total Current Liabilities	0.9	0.88		0.8	0.89	0.79	-0.37	-0.81	0.95	0.64	0.79	-0.8	0.88	0.54	0.92	0.53	0.65	-0.55	0.74	0.84	0.7	-0.5	0.88	0.8	0.89	0.88
Total Stockholder Equity	0.86	0.59	0.8		0.96	0.64	-0.54	-0.57	0.84	0.66	0.64	-0.59	0.86	0.14	0.87	0.39	0.68	-0.85	0.53	0.83	0.4	-0.82	0.97	0.65	0.86	0.86
Net Tangible Assets	0.88	0.65	0.89	0.96		0.75	-0.36	-0.74	0.91	0.57	0.75	-0.74	0.87	0.4	0.95	0.52	0.73	-0.82	0.7	0.87	0.6	-0.79	1.0	0.77	0.88	0.87
Property Plant And Equipment Net	0.58	0.69	0.79	0.64	0.75		0.11	-0.91	0.66	0.11	1.0	-0.97	0.53	0.62	0.9	0.79	0.72	-0.6	0.85	0.88	0.85	-0.56	0.74	1.0	0.57	0.55
Net Debt	-0.56	-0.33	-0.37	-0.54	-0.36	0.11		-0.18	-0.45	-0.93	0.11	-0.21	-0.59	0.52	-0.22	0.23	-0.03	0.19	0.19	-0.22	0.36	0.16	-0.38	0.09	-0.57	-0.58
Retained Earnings	-0.63	-0.66	-0.81	-0.57	-0.74	-0.91	-0.18		-0.74	-0.13	-0.91	0.97	-0.59	-0.82	-0.87	-0.85	-0.54	0.51	-0.98	-0.83	-0.98	0.48	-0.73	-0.93	-0.62	-0.6
Accounts Payable	0.96	0.71	0.95	0.84	0.91	0.66	-0.45	-0.74		0.72	0.66	-0.68	0.95	0.48	0.89	0.48	0.59	-0.53	0.68	0.81	0.61	-0.48	0.91	0.69	0.96	0.95
Cash	0.77	0.54	0.64	0.66	0.57	0.11	-0.93	-0.13	0.72		0.11	-0.06	0.8	-0.17	0.46	-0.03	0.17	-0.26	0.11	0.41	-0.04	-0.22	0.58	0.14	0.78	0.78
Non Current Assets Total	0.58	0.69	0.79	0.64	0.75	1.0	0.11	-0.91	0.66	0.11		-0.97	0.53	0.62	0.9	0.79	0.72	-0.6	0.85	0.88	0.85	-0.56	0.74	1.0	0.57	0.55
Non Currrent Assets Other	-0.6	-0.69	-0.8	-0.59	-0.74	-0.97	-0.21	0.97	-0.68	-0.06	-0.97		-0.55	-0.77	-0.86	-0.78	-0.68	0.57	-0.92	-0.86	-0.94	0.54	-0.73	-0.97	-0.58	-0.57
Cash And Short Term Investments	1.0	0.65	0.88	0.86	0.87	0.53	-0.59	-0.59	0.95	0.8	0.53	-0.55		0.29	0.78	0.32	0.55	-0.51	0.54	0.8	0.44	-0.47	0.87	0.55	1.0	1.0
Net Receivables	0.33	0.42	0.54	0.14	0.4	0.62	0.52	-0.82	0.48	-0.17	0.62	-0.77	0.29		0.52	0.56	0.41	-0.15	0.77	0.42	0.89	-0.13	0.38	0.63	0.32	0.3
Common Stock Total Equity	0.81	0.73	0.92	0.87	0.95	0.9	-0.22	-0.87	0.89	0.46	0.9	-0.86	0.78	0.52		0.69	0.72	-0.73	0.82	0.91	0.75	-0.69	0.94	0.91	0.8	0.79
Common Stock Shares Outstanding	0.37	0.34	0.53	0.39	0.52	0.79	0.23	-0.85	0.48	-0.03	0.79	-0.78	0.32	0.56	0.69		0.19	-0.39	0.91	0.73	0.84	-0.37	0.51	0.81	0.36	0.34
Short Term Investments	0.57	0.57	0.65	0.68	0.73	0.72	-0.03	-0.54	0.59	0.17	0.72	-0.68	0.55	0.41	0.72	0.19		-0.64	0.39	0.63	0.44	-0.62	0.73	0.69	0.56	0.55
Non Current Liabilities Total	-0.53	-0.43	-0.55	-0.85	-0.82	-0.6	0.19	0.51	-0.53	-0.26	-0.6	0.57	-0.51	-0.15	-0.73	-0.39	-0.64		-0.51	-0.66	-0.41	1.0	-0.83	-0.6	-0.52	-0.52
Capital Surpluse	0.58	0.57	0.74	0.53	0.7	0.85	0.19	-0.98	0.68	0.11	0.85	-0.92	0.54	0.77	0.82	0.91	0.39	-0.51		0.81	0.97	-0.48	0.69	0.88	0.57	0.55
Other Current Assets	0.83	0.65	0.84	0.83	0.87	0.88	-0.22	-0.83	0.81	0.41	0.88	-0.86	0.8	0.42	0.91	0.73	0.63	-0.66	0.81		0.71	-0.63	0.87	0.88	0.82	0.81
Other Stockholder Equity	0.48	0.57	0.7	0.4	0.6	0.85	0.36	-0.98	0.61	-0.04	0.85	-0.94	0.44	0.89	0.75	0.84	0.44	-0.41	0.97	0.71		-0.38	0.59	0.86	0.47	0.45
Total Liab	-0.48	-0.38	-0.5	-0.82	-0.79	-0.56	0.16	0.48	-0.48	-0.22	-0.56	0.54	-0.47	-0.13	-0.69	-0.37	-0.62	1.0	-0.48	-0.63	-0.38		-0.8	-0.57	-0.48	-0.47
Net Invested Capital	0.89	0.65	0.88	0.97	1.0	0.74	-0.38	-0.73	0.91	0.58	0.74	-0.73	0.87	0.38	0.94	0.51	0.73	-0.83	0.69	0.87	0.59	-0.8		0.76	0.88	0.88
Property Plant And Equipment Gross	0.59	0.7	0.8	0.65	0.77	1.0	0.09	-0.93	0.69	0.14	1.0	-0.97	0.55	0.63	0.91	0.81	0.69	-0.6	0.88	0.88	0.86	-0.57	0.76		0.58	0.56
Total Current Assets	1.0	0.66	0.89	0.86	0.88	0.57	-0.57	-0.62	0.96	0.78	0.57	-0.58	1.0	0.32	0.8	0.36	0.56	-0.52	0.57	0.82	0.47	-0.48	0.88	0.58		1.0
Net Working Capital	1.0	0.64	0.88	0.86	0.87	0.55	-0.58	-0.6	0.95	0.78	0.55	-0.57	1.0	0.3	0.79	0.34	0.55	-0.52	0.55	0.81	0.45	-0.47	0.88	0.56	1.0

Click cells to compare fundamentals

Milestone Pharmaceuticals Account Relationship Matchups

Milestone Pharmaceuticals balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	123.4M	150.0M	119.8M	74.5M	75.2M	103.5M
Other Current Liab	3.6M	1.0M	1.9M	2.9M	2.2M	2.3M
Total Current Liabilities	8.3M	6.2M	6.8M	6.1M	7.2M	6.4M
Total Stockholder Equity	114.9M	143.1M	112.6M	66.3M	16.8M	15.9M
Net Tangible Assets	114.9M	143.1M	112.6M	66.3M	76.3M	63.9M
Property Plant And Equipment Net	929K	1.3M	926K	2.7M	2.2M	1.3M
Net Debt	(119.3M)	(71.4M)	(113.4M)	(5.1M)	38.0M	39.9M
Retained Earnings	(113.5M)	(163.5M)	(206.3M)	(266.3M)	(326.0M)	(309.7M)
Accounts Payable	4.4M	4.6M	4.4M	2.3M	4.0M	3.6M
Cash	119.8M	72.3M	114.1M	7.6M	13.8M	13.1M
Non Current Assets Total	929K	1.3M	926K	2.7M	2.2M	1.3M
Non Currrent Assets Other	(929K)	(1.3M)	(926K)	(2.7M)	(2.4M)	(2.3M)
Cash And Short Term Investments	119.8M	142.3M	114.1M	64.6M	66.0M	97.4M
Net Receivables	836K	948K	483K	1.2M	3.9M	4.0M
Common Stock Total Equity	2.0M	226.2M	251.7M	251.9M	289.7M	161.3M
Common Stock Shares Outstanding	15.8M	29.3M	41.8M	42.5M	43.0M	34.5M
Liabilities And Stockholders Equity	123.4M	150.0M	119.8M	74.5M	75.2M	103.5M
Non Current Liabilities Total	184K	696K	474K	2.0M	51.2M	28.9M
Capital Surpluse	2.7M	3.8M	8.5M	15.7M	18.1M	19.0M
Inventory	(578K)	(725K)	(356K)	(331K)	(297.9K)	(312.8K)
Other Current Assets	2.4M	5.4M	4.3M	6.0M	3.2M	3.6M
Other Stockholder Equity	3.8M	8.5M	15.7M	24.4M	33.8M	35.5M
Total Liab	8.5M	6.9M	7.2M	8.1M	58.5M	33.5M
Net Invested Capital	114.9M	143.1M	112.6M	66.3M	66.5M	65.2M
Property Plant And Equipment Gross	978K	1.3M	1.2M	2.7M	2.4M	1.3M
Total Current Assets	122.5M	148.7M	118.9M	71.8M	73.0M	102.2M
Net Working Capital	114.2M	142.5M	112.1M	65.7M	65.8M	95.8M
Short Term Debt	330K	490K	448K	990K	1.1M	1.1M
Common Stock	226.2M	251.7M	251.9M	273.9M	260.5M	199.2M
Property Plant Equipment	929K	1.3M	215K	2.7M	3.1M	3.2M
Capital Stock	226.2M	251.7M	251.9M	273.9M	260.5M	232.1M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Milestone Stock Analysis

When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Milestone Historical Balance Sheet

Milestone Pharmaceuticals Inventory

(312,795)

About Milestone Balance Sheet Analysis

Milestone Pharmaceuticals Balance Sheet Chart

Total Current Liabilities

Property Plant And Equipment Net

Good Will

Milestone Pharmaceuticals balance sheet Correlations

Milestone Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Milestone Pharmaceuticals balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Milestone Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Net Tangible Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net

Other Stockholder Equity	- 0.98	Retained Earnings
Capital Surpluse	- 0.98	Retained Earnings
Property Plant And Equipment Gross	- 0.97	Non Currrent Assets Other
Non Currrent Assets Other	- 0.97	Non Current Assets Total
Non Currrent Assets Other	- 0.97	Property Plant And Equipment Net
Other Stockholder Equity	- 0.94	Non Currrent Assets Other